News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LAMATTINA JOHN L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 01/17/2023 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 15,125 shares
@ $4, valued at
$60.5k
|
|
| 12/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 4,835 shares
@ $161.8571, valued at
$782.6k
Exercised 4,835 options to buy
@ $32.3, valued at
$156.2k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2020 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 7,500 options to buy
@ $11.38, valued at
$85.4k
|
|
| 10/08/2020 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Converted 46,388 shares
@ $0
Converted 46,388 convertible preferred
@ $0
Converted 11,111 warrants
@ $9, valued at
$100k
|
|
| 06/12/2020 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 831 shares
@ $0
Granted 2,468 options to buy
@ $117.58, valued at
$290.2k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 835 shares
@ $0
Granted 4,071 options to buy
@ $113.59, valued at
$462.4k
|
|
| 01/28/2019 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 10,844 shares
@ $4.38, valued at
$47.5k
|
|
| 09/05/2018 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 3,335 shares
@ $254.9601, valued at
$850.3k
Exercised 3,335 options to buy
@ $12.53, valued at
$41.8k
|
|
| 06/21/2018 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 493 shares
@ $0
Granted 2,474 options to buy
@ $76.77, valued at
$189.9k
|
|
| 06/07/2018 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 20,000 options to buy
@ $6.79, valued at
$135.8k
|
|
| 06/04/2018 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 4,000 shares
@ $194.5097, valued at
$778k
Exercised 4,000 options to buy
@ $12.53, valued at
$50.1k
|
|
| 03/06/2018 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 3,335 shares
@ $160.9007, valued at
$536.6k
Exercised 3,335 options to buy
@ $10.12, valued at
$33.8k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2017 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 4,000 shares
@ $139.79, valued at
$559.2k
Exercised 4,000 options to buy
@ $10.12, valued at
$40.5k
|
|
| 06/23/2017 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 14,500 options to buy
@ $3.95, valued at
$57.3k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2017 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on ZAFGEN, INC. |
| 07/01/2016 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 12,000 options to buy
@ $5.99, valued at
$71.9k
|
|
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2013 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,925 shares
@ $0
Granted 696 shares
@ $0
Granted 7,335 options to buy
@ $32.3, valued at
$236.9k
|
|
| 08/01/2012 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Disposed/sold 4,166 shares
@ $14.25, valued at
$59.4k
Unknown transaction of 42,843 shares
@ $14.25, valued at
$610.5k
Disposed/sold 25,000 options to buy
@ $5.71, valued at
$142.8k
Disposed/sold 3,991 options to buy
@ $2.09, valued at
$8.3k
Disposed/sold 16,000 options to buy
@ $14.23, valued at
$227.7k
|
|
| 05/31/2012 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,925 shares
@ $0
Granted 1,796 shares
@ $0
Granted 7,335 options to buy
@ $12.53, valued at
$91.9k
|
|
| 05/21/2012 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 16,000 options to buy
@ $14.23, valued at
$227.7k
|
|
| 06/03/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2011 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 16,000 options to buy
@ $27.51, valued at
$440.2k
|
|
|
|
|